Centre for Bioengineering and Biotechnology
University of Waterloo, East Campus 4, Room 2001
200 University Avenue West
Waterloo , Ontario, N2L 3G1 Canada
519-888-4567 Ext 32732
The Centre for Bioengineering and Biotechnology is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.
More than 130 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.
Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.
To learn more about partnerships, please email us.
At the Centre for Bioengineering and Biotechnology, we have over 130 researchers working in areas as diverse as new pharmaceutical delivery systems, lab testing on technologies as small as a computer chip, better and lower cost imaging systems, and software solutions for healthcare. Our researchers span all departments of the faculties of engineering and science, and includes researchers from other faculties as well. The common thread between researchers is a dedication to understanding how technology can work in conjunction with biology and people to make a better world.
The Centre for Bioengineering and Biotechnology is focused on partnerships. Success in this area requires strong partnerships between researchers, students, industry, healthcare and government. For this reason, the Centre welcomes members from these communities and encourages them to join the Centre and participate in our research. We host industry focus days, seminars, workshops, student events, and help build the right teams to tackle the toughest problems. Come join us, and work towards a better, healthier world through technology.
- Catherine Burns, Director, Centre for Bioengineering and Biotechnology
CBB Member Emmanuel Ho and collaborators from the University of Manitoba have created a new therapy to combat deadly bacteria infecting hospital patients worldwide.
The new therapy is a biocide able to target antibiotic-defiant bacteria such as Methicillin resistant Staphylococcus aureus (MRSA). The team's goal was to find a way around the superbug's defences, using a new approach based on material science.
Karly Smith, 3A biomedical engineering studen at UW and student of CBB member George Shaker, has qualified to the Top 75 in Canada for NSERC's Science, Action! Competition.
CBB member Edith Law is actively working on CrowdEEG, an innovative tool for medical time series data.
Tuesday January 16 - 12:30-2:30 pm – IP 101 and Commercialization
Tuesday February 13 - 12:30-2:00 pm – IP Case Study
Tuesday March 13 - 12:30-2:00 pm – Copyright and Software
Tuesday April 10 - 12:30-2:00 pm – Trademarks
Supported by CBB, from April 16 – 19, the 13th International Conference on Persuasive Technology will be hosted in Canada at the University of Waterloo.